• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form POS EX filed by TeklaLife Sciences Investors

    9/27/23 9:33:33 AM ET
    $HQL
    Investment Managers
    Finance
    Get the next $HQL alert in real time by email
    POS EX 1 tm2326781d2_posex.htm POS EX

     

    As filed with the Securities and Exchange Commission on September 27, 2023

     

    Securities Act File No. 333-195326
    Investment Company Act File No. 811-06565

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM N-2

     

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 x

     

    Pre-Effective Amendment No.

    Post-Effective Amendment No. 11

     

    REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 x

     

    Amendment No. 27

     

    TEKLA LIFE SCIENCES INVESTORS

    (Exact Name of Registrant as Specified in Charter)

     

    100 Federal Street, 19th Floor

    Boston, MA 02110

    (617) 772-8500

    (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s
    Principal Executive Offices)

     

    Daniel R. Omstead, Ph.D.

    100 Federal Street, 19th Floor

    Boston, MA 02110

    (Name, address including zip code, and telephone number, including area code, of agent for
    service)

     

    With Copies to:

     

    Christopher P. Harvey, Esq.

    Dechert LLP

    One International Place, 40th Floor

    100 Oliver Street

    Boston, MA 02110

     

    Approximate Date of Proposed Public Offering: As soon as practicable after the effective date of this Registration Statement

     

    If any securities being registered on this form will be offered on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933, other than securities offered in connection with a dividend reinvestment plan, check the following box ¨.

     

    This post-effective amendment will become effective immediately pursuant to Rule 462(d).

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Post-Effective Amendment No. 11 to the Registration Statement on Form N-2 (File No. 333-195326) of Tekla Life Sciences Investors (the “Registration Statement”) is being filed pursuant to Rule 462(d) under the Securities Act of 1933, as amended (the “Securities Act”), solely for the purpose of filing an exhibit to the Registration Statement. No changes have been made to Part A, Part B or Part C of the Registration Statement, other than the Items of Part C of the Registration Statement as set forth below. Accordingly, this Post-Effective Amendment No. 11 consists only of a facing page, this explanatory note and Part C of the Registration Statement on Form N-2 setting forth the exhibits to the Registration Statement. This Post-Effective Amendment No. 11 does not modify any other part of the Registration Statement. The contents of the Registration Statement are hereby incorporated by reference.

     

    2

     

     

    PART C: OTHER INFORMATION

     

    Item 25. Financial Statements and Exhibits

     

    2.Exhibits:

     

    a.(i) Amended and Restated Declaration of Trust of the Registrant, dated February 20, 1992(1)

     

    (ii)Amendment relating to requirements for Conversion dated March 26, 1992(1)

     

    (iii)Notice of Change of Trustee, dated August 11, 1995(1)

     

    (iv)Acceptance of Trustee Appointment, dated March 30, 2000(1)

     

    (v)Notice of Change of Trustee, dated April 14, 2003(1)

     

    (vi)Acceptance of Trustee appointment, dated June 2, 2003(1)

     

    (vii)Notice of Change of Trustee, dated August 9, 2006(3)

     

    (viii)Notice of Change of Trustee, dated July 2, 2007(3)

     

    (ix)Notice of Change of Trustee, dated June 8, 2010(3)

     

    (x)Amendment relating to Repurchase of Shares, dated May 3, 2011(2)

     

    (xi)Notice of Change of Trustee, dated June 29, 2011(3)

     

    (xii)Notice of Change of Trustee, dated December 14, 2011(3)

     

    (xiii)Notice of Change of Trustee, dated May 2, 2012(3)

     

    (xiv)Notice of Change of Trustee, dated December 20, 2017(7)

     

    (xv)Notice of Change of Trustee, dated December 13, 2018(8)

     

    (xvi)Notice of Change of Trustee, dated June 20, 2019(9)

     

    (xvii)Notice of Change of Trustee, dated August 27, 2020(11)
       
     (xviii) Notice of Change of Trustee, dated June 16, 2021(12)
       
    (xix)Notice of Change of Trustee, dated December 13, 2021(13)
       
     (xx) Notice of Change of Trustee, dated June 16, 2022(14)
       
     (xxi)Notice of Change of Trustee, dated July 14, 2022(15)

     

    b.By-Laws of the Registrant, as amended, filed herewith

     

    c.Not applicable

     

    d.(i) Specimen certificate for Shares of Beneficial Interest(1)

     

      (ii)Form of Exercise Form(6)

     

    e.Dividend Reinvestment and Cash Purchase plan(1)

     

    f.Not applicable

     

    3

     

     

    g.Investment Advisory Agreement, dated as of July 1, 2009, between the Registrant and Tekla Capital Management LLC (formerly known as Hambrecht & Quist Capital Management, LLC)(3)

     

    h.Not applicable

     

    i.Not applicable

     

    j.Custodian Agreement, dated September 30, 2004, between the Registrant and State Street Bank and Trust Company(1)

     

    k.(i)        Administration Agreement between Registrant and State Street Bank and Trust Company, dated as of July 1, 2005(1)

     

    (ii)     Transfer Agency and Service Agreement between Registrant, Computershare Trust Company, N.A. and Computershare Shareholder Services, Inc. (formerly known as EquiServe, Inc.), dated as of March 1, 2006(3)

     

    (iii)      Information Agent Agreement between the Registrant and AST Fund Solutions, LLC, dated April 21, 2014(5)

     

    (iv)     Subscription Agent Agreement between the Registrant and Boston Financial Data Services, Inc., dated April 30, 2014(10)

     

    (v)      Support Services Agreement between the Registrant and Destra Capital Investments LLC dated January 1, 2016 (6)

     

    (vi)     Assignment of the Support Services Agreement with Destra Capital Investments LLC to Destra Capital Advisors LLC dated April 2, 2018(7)

     

    l.Opinion and Consent of Dechert LLP(5)

     

    m.Not applicable

     

    n.(i)        Consent of Deloitte & Touche LLP, filed on May 28, 2014(6)

     

    (ii)       Powers of Attorney dated March 28, 2014 and April 2, 2014(3); Power of Attorney dated April 9, 2018(7); Power of Attorney dated December 13, 2018(8); Power of Attorney dated August 27, 2020(11), Power of Attorney dated November 30, 2021, (13), Power of Attorney dated June 9, 2022(14)

     

    o.Not applicable

     

    p.Not applicable

     

    q.Not applicable

     

    r.Code of Ethics of Registrant(3)

     

    4

     

     

     

    (1)Incorporated by reference from Form N-2 Registration Statement (1933 File No. 333-133245; 1940 Act File No. 811-06565), filed on April 12, 2006.

     

    (2)Incorporated by reference from Form N-2/A Registration Statement (1940 Act File No. 811-06565), filed on July 5, 2011.

     

    (3)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed on April 16, 2014.

     

    (4)Incorporated by reference from Form N-2/A Registration Statement (1940 Act File No. 811-06565), filed on December 28, 2012.

     

    (5)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed on May 23, 2014.

     

    (6)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed on May 28, 2014.

     

    (7)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed on April 18, 2018.

     

    (8)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed on March 12, 2019.

     

    (9)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed June 20, 2019.

     

    (10)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed June 19, 2017.

     

    (11)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed September 10, 2020.
       
    (12)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed July 2, 2021.
       
     (13)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed December 22, 2021.
       
     (14)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed July 1, 2022.
       
     (15)Incorporated by reference from Form N-2 Registration Statement (1933 Act File No. 333-195326; 1940 Act File No. 811-06565), filed July 29, 2022.

     

    5

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has duly caused this Post-Effective Amendment No. 11 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boston and Commonwealth of Massachusetts on the 27th day of September, 2023.

     

      TEKLA LIFE SCIENCES INVESTORS
       
       
      By: /s/ Daniel R. Omstead
        President

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Name   Title   Date
             
    /s/ Daniel R. Omstead   Trustee and President (Principal Executive Officer)   September 27, 2023
    Daniel R. Omstead      
             
    /s/ Laura Woodward   Treasurer (Principal Financial Officer)   September 27, 2023
    Laura Woodward        
             
    /s/ Jeffrey A. Bailey***   Trustee and Chairman of the Board   September 27, 2023
    Jeffrey A. Bailey        
             
    /s/ Kathleen L. Goetz****   Trustee   September 27, 2023
    Kathleen L. Goetz        
             
    /s/ Rakesh K. Jain*   Trustee   September 27, 2023
    Rakesh K. Jain        
             
    /s/ Thomas M. Kent**   Trustee   September 27, 2023
    Thomas M. Kent        
             
    /s/ W. Mark Watson*****   Trustee   September 27, 2023
    W. Mark Watson        

     

    *By: Daniel R. Omstead as attorney-in-fact of each person so indicated and pursuant to the power of attorney previously filed on April 16, 2014.

     

    **By: Daniel R. Omstead as attorney-in-fact of each person so indicated and pursuant to the power of attorney previously filed on April 18, 2018.

     

    *** By: Daniel R. Omstead as attorney-in-fact of each person so indicated and pursuant to the power of attorney previously filed on September 10, 2020.

     

    **** By: Daniel R. Omstead as attorney-in-fact of each person so indicated and pursuant to the power of attorney previously filed on December 22, 2021.

     

    *****By: Daniel R. Omstead as attorney-in-fact of each person so indicated and pursuant to the power of attorney previously filed on July 1, 2022.

     

    6

     

     

    EXHIBIT LIST

     

    (b)   By-Laws of the Registrant, as amended

     

    7

    Get the next $HQL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HQL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HQL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pittard Christian bought $133,755 worth of shares (7,923 units at $16.88) (SEC Form 4)

    4 - abrdn Life Sciences Investors (0000884121) (Issuer)

    12/18/25 11:16:37 AM ET
    $HQL
    Investment Managers
    Finance

    Director Maher Bill bought $9,990 worth of shares (650 units at $15.37) (SEC Form 4)

    4 - abrdn Life Sciences Investors (0000884121) (Issuer)

    8/27/24 2:46:40 PM ET
    $HQL
    Investment Managers
    Finance

    Director Dimartino Rose bought $15,530 worth of shares (1,000 units at $15.53) (SEC Form 4)

    4 - abrdn Life Sciences Investors (0000884121) (Issuer)

    7/18/24 2:56:19 PM ET
    $HQL
    Investment Managers
    Finance

    $HQL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

    PHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on March 31, 2026 to all shareholders of rec

    2/10/26 4:17:00 PM ET
    $ACP
    $AGD
    $AOD
    Investment Managers
    Finance
    Trusts Except Educational Religious and Charitable
    Finance Companies

    Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

    PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 12, 2026, on a per share basis to all shareholders of record as of December 31, 2025 (ex-dividend date December 31, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on January 12, 2026, to all shareholders of record as of November 21, 2025 (ex-dividend da

    1/12/26 4:17:00 PM ET
    $ASGI
    $HQH
    $HQL
    Investment Managers
    Finance
    Finance Companies
    Finance/Investors Services

    ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

    PHILADELPHIA, Nov. 11, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on November 28, 2025 to all shareholders of record as of November 21, 2025 (ex-dividend date November 21, 2025). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on January 12, 2026, to all shareholders of

    11/11/25 4:17:00 PM ET
    $ACP
    $AGD
    $AOD
    Investment Managers
    Finance
    Trusts Except Educational Religious and Charitable
    Finance/Investors Services

    $HQL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Reilly Heather Carter

    3 - abrdn Life Sciences Investors (0000884121) (Issuer)

    12/19/25 4:01:26 PM ET
    $HQL
    Investment Managers
    Finance

    Director Pittard Christian bought $133,755 worth of shares (7,923 units at $16.88) (SEC Form 4)

    4 - abrdn Life Sciences Investors (0000884121) (Issuer)

    12/18/25 11:16:37 AM ET
    $HQL
    Investment Managers
    Finance

    Large owner Saba Capital Management, L.P. sold $687,094 worth of shares (48,612 units at $14.13) (SEC Form 4)

    4 - abrdn Life Sciences Investors (0000884121) (Issuer)

    9/23/25 1:50:58 PM ET
    $HQL
    Investment Managers
    Finance

    $HQL
    SEC Filings

    View All

    SEC Form N-CSR filed by abrdn Life Sciences Investors Shares of Beneficial Interest

    N-CSR - abrdn Life Sciences Investors (0000884121) (Filer)

    12/8/25 4:52:33 PM ET
    $HQL
    Investment Managers
    Finance

    SEC Form N-CEN filed by abrdn Life Sciences Investors Shares of Beneficial Interest

    N-CEN - abrdn Life Sciences Investors (0000884121) (Filer)

    12/8/25 2:56:49 PM ET
    $HQL
    Investment Managers
    Finance

    SEC Form N-PX filed by abrdn Life Sciences Investors Shares of Beneficial Interest

    N-PX - abrdn Life Sciences Investors (0000884121) (Filer)

    8/29/25 1:58:50 PM ET
    $HQL
    Investment Managers
    Finance

    $HQL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by abrdn Life Sciences Investors Shares of Beneficial Interest (Amendment)

    SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)

    6/3/24 9:15:41 AM ET
    $HQL
    Investment Managers
    Finance

    SEC Form SC 13D/A filed by abrdn Life Sciences Investors Shares of Beneficial Interest (Amendment)

    SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)

    4/29/24 10:52:45 AM ET
    $HQL
    Investment Managers
    Finance

    SEC Form SC 13D/A filed by abrdn Life Sciences Investors Shares of Beneficial Interest (Amendment)

    SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)

    4/17/24 8:32:11 AM ET
    $HQL
    Investment Managers
    Finance

    $HQL
    Leadership Updates

    Live Leadership Updates

    View All

    abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

    PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has

    3/21/24 7:59:00 AM ET
    $AWP
    $HQH
    $HQL
    Trusts Except Educational Religious and Charitable
    Finance
    Finance Companies
    Investment Managers

    $HQL
    Financials

    Live finance-specific insights

    View All

    Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

    PHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on March 31, 2026 to all shareholders of rec

    2/10/26 4:17:00 PM ET
    $ACP
    $AGD
    $AOD
    Investment Managers
    Finance
    Trusts Except Educational Religious and Charitable
    Finance Companies

    Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

    PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 12, 2026, on a per share basis to all shareholders of record as of December 31, 2025 (ex-dividend date December 31, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on January 12, 2026, to all shareholders of record as of November 21, 2025 (ex-dividend da

    1/12/26 4:17:00 PM ET
    $ASGI
    $HQH
    $HQL
    Investment Managers
    Finance
    Finance Companies
    Finance/Investors Services

    ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

    PHILADELPHIA, Nov. 11, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on November 28, 2025 to all shareholders of record as of November 21, 2025 (ex-dividend date November 21, 2025). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on January 12, 2026, to all shareholders of

    11/11/25 4:17:00 PM ET
    $ACP
    $AGD
    $AOD
    Investment Managers
    Finance
    Trusts Except Educational Religious and Charitable
    Finance/Investors Services